A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive to radiation in specific parts of the rectum than others. The knowledge could reduce the risk of severe bowel complications from radiotherapy, known as rectal toxicity, heralding a more personalized approach to prostate cancer treatment. The study is published in Clinical Cancer Research.
This article was originally published on MedicalXpress.com